Ask AI
ProCE Banner Activity

ANRS Prévenir: Final Results of Prospective Observational Cohort Study of Daily or On-Demand Oral FTC/TDF HIV PrEP

Conference Coverage
Slideset

In this cohort predominantly made up of French-born men who have sex with men, there was a high rate of switching between daily and on-demand oral FTC/TDF PrEP, a low HIV incidence, and a high rate of study retention over more than 8 years.

Released: February 27, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions